Marcel Tanner
Chairman at Malaria Consortium
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Paul Herrling | M | 78 |
University of Basel
Swiss Federal Institute of Technology
| 16 years |
Suerie Moon | M | - |
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative BiotechnologyHealth Technology Drugs for Neglected Diseases initiative provides drug research and development services. It specializes in analyzing the causes of and in developing medicine and treatments for neglected diseases. It specializes in the study of neglected tropical diseases, such as sleeping sickness (Human African Trypanosomiasis), Leishmaniasis, Chagas, malaria, pediatric HIV, and filarial diseases. It develops a research and development portfolio that includes projects from discovery through to post-registration phases. Its focus areas encompass regional disease-specific platform development, technology transfer, and public responsibility and awareness advocacies. The organization was founded in July 2003 and is headquartered in Geneva, Switzerland. | - |
Markus Gross | M | - |
Swiss Federal Institute of Technology
| - |
Catharina Boehme | F | - |
Foundation for Innovative New Diagnostics
Foundation for Innovative New Diagnostics Medical/Nursing ServicesHealth Services Foundation for Innovative New Diagnostics provides healthcare services. It enables the development and delivery of much-needed diagnostic tests for poverty-related diseases, including tuberculosis, malaria, HIV/AIDS, sleeping sickness, hepatitis C, leishmaniasis, Chagas disease, Buruli ulcer, febrile illnesses and infectious diseases with outbreak potential, such as Ebola. The company was founded in 2003 and is headquartered in Geneva, Switzerland. | 19 years |
Canisius Anthony | M | - |
Malaria Consortium
Malaria Consortium Medical/Nursing ServicesHealth Services Malaria Consortium is a non-profit organization that specializes in preventing, controlling, and treating malaria and other communicable diseases among vulnerable populations. The non-profit company is based in London, UK. Malaria Consortium's evidence-based programs combat targeted diseases and promote universal health coverage in Africa and Asia. The British company was founded in 2003 by Sylvia Meek, and the CEO is Charles Nelson. | - |
Robert-Jan Bumbacher | M | - |
Universitätsspital Basel
Universitätsspital Basel Hospital/Nursing ManagementHealth Services Universitätsspital Basel provides medical services. It offers medical facilities for the welfare, safety and recovery of patients. The company is headquartered in Basel, Switzerland. | - |
Stefan Catsicas | M | 66 |
Swiss Federal Institute of Technology
| - |
Beat Oberlin | M | 69 |
University of Basel
| 6 years |
Barbara Kessler | M | - |
Universitätsspital Basel
Universitätsspital Basel Hospital/Nursing ManagementHealth Services Universitätsspital Basel provides medical services. It offers medical facilities for the welfare, safety and recovery of patients. The company is headquartered in Basel, Switzerland.
University of Basel
| - |
Gerhard Schmid | M | - |
Universitätsspital Basel
Universitätsspital Basel Hospital/Nursing ManagementHealth Services Universitätsspital Basel provides medical services. It offers medical facilities for the welfare, safety and recovery of patients. The company is headquartered in Basel, Switzerland. | - |
Grégoire Courtine | M | 49 |
Swiss Federal Institute of Technology
| - |
Carlos Morel | M | - |
Foundation for Innovative New Diagnostics
Foundation for Innovative New Diagnostics Medical/Nursing ServicesHealth Services Foundation for Innovative New Diagnostics provides healthcare services. It enables the development and delivery of much-needed diagnostic tests for poverty-related diseases, including tuberculosis, malaria, HIV/AIDS, sleeping sickness, hepatitis C, leishmaniasis, Chagas disease, Buruli ulcer, febrile illnesses and infectious diseases with outbreak potential, such as Ebola. The company was founded in 2003 and is headquartered in Geneva, Switzerland. | - |
Bernhards Ogutu | M | - |
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative BiotechnologyHealth Technology Drugs for Neglected Diseases initiative provides drug research and development services. It specializes in analyzing the causes of and in developing medicine and treatments for neglected diseases. It specializes in the study of neglected tropical diseases, such as sleeping sickness (Human African Trypanosomiasis), Leishmaniasis, Chagas, malaria, pediatric HIV, and filarial diseases. It develops a research and development portfolio that includes projects from discovery through to post-registration phases. Its focus areas encompass regional disease-specific platform development, technology transfer, and public responsibility and awareness advocacies. The organization was founded in July 2003 and is headquartered in Geneva, Switzerland. | - |
Alan Tyndall | M | 76 |
University of Basel
| 33 years |
Antonio Lanzavecchia | M | 73 |
Swiss Federal Institute of Technology
| - |
Sylvia Schenker | F | - |
Universitätsspital Basel
Universitätsspital Basel Hospital/Nursing ManagementHealth Services Universitätsspital Basel provides medical services. It offers medical facilities for the welfare, safety and recovery of patients. The company is headquartered in Basel, Switzerland. | - |
Wolf-Dietrich Hardt | M | - |
Swiss Federal Institute of Technology
| - |
Jorge Bermudez | M | - |
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative BiotechnologyHealth Technology Drugs for Neglected Diseases initiative provides drug research and development services. It specializes in analyzing the causes of and in developing medicine and treatments for neglected diseases. It specializes in the study of neglected tropical diseases, such as sleeping sickness (Human African Trypanosomiasis), Leishmaniasis, Chagas, malaria, pediatric HIV, and filarial diseases. It develops a research and development portfolio that includes projects from discovery through to post-registration phases. Its focus areas encompass regional disease-specific platform development, technology transfer, and public responsibility and awareness advocacies. The organization was founded in July 2003 and is headquartered in Geneva, Switzerland. | - |
Joanne Liu | M | - |
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative BiotechnologyHealth Technology Drugs for Neglected Diseases initiative provides drug research and development services. It specializes in analyzing the causes of and in developing medicine and treatments for neglected diseases. It specializes in the study of neglected tropical diseases, such as sleeping sickness (Human African Trypanosomiasis), Leishmaniasis, Chagas, malaria, pediatric HIV, and filarial diseases. It develops a research and development portfolio that includes projects from discovery through to post-registration phases. Its focus areas encompass regional disease-specific platform development, technology transfer, and public responsibility and awareness advocacies. The organization was founded in July 2003 and is headquartered in Geneva, Switzerland. | - |
Albert Urwyler | M | - |
Universitätsspital Basel
Universitätsspital Basel Hospital/Nursing ManagementHealth Services Universitätsspital Basel provides medical services. It offers medical facilities for the welfare, safety and recovery of patients. The company is headquartered in Basel, Switzerland. | - |
Helma Wennemers | M | 55 |
Swiss Federal Institute of Technology
| 13 years |
Maunatlala Mehlape | M | 58 |
Foundation for Innovative New Diagnostics
Foundation for Innovative New Diagnostics Medical/Nursing ServicesHealth Services Foundation for Innovative New Diagnostics provides healthcare services. It enables the development and delivery of much-needed diagnostic tests for poverty-related diseases, including tuberculosis, malaria, HIV/AIDS, sleeping sickness, hepatitis C, leishmaniasis, Chagas disease, Buruli ulcer, febrile illnesses and infectious diseases with outbreak potential, such as Ebola. The company was founded in 2003 and is headquartered in Geneva, Switzerland. | 20 years |
Helga Nowotny | M | 87 |
Swiss Federal Institute of Technology
| - |
Laurent Vulliet | M | 66 |
Swiss Federal Institute of Technology
| 30 years |
Philippe Renaud | M | - |
Swiss Federal Institute of Technology
| 31 years |
Jacqueline Henn Overbeck | M | 64 |
University of Basel
| 20 years |
Irmtraut Gürkan | F | - |
Universitätsspital Basel
Universitätsspital Basel Hospital/Nursing ManagementHealth Services Universitätsspital Basel provides medical services. It offers medical facilities for the welfare, safety and recovery of patients. The company is headquartered in Basel, Switzerland. | - |
Peter Meler-Abt | M | - |
Universitätsspital Basel
Universitätsspital Basel Hospital/Nursing ManagementHealth Services Universitätsspital Basel provides medical services. It offers medical facilities for the welfare, safety and recovery of patients. The company is headquartered in Basel, Switzerland. | - |
Andrew Jack | M | - |
Foundation for Innovative New Diagnostics
Foundation for Innovative New Diagnostics Medical/Nursing ServicesHealth Services Foundation for Innovative New Diagnostics provides healthcare services. It enables the development and delivery of much-needed diagnostic tests for poverty-related diseases, including tuberculosis, malaria, HIV/AIDS, sleeping sickness, hepatitis C, leishmaniasis, Chagas disease, Buruli ulcer, febrile illnesses and infectious diseases with outbreak potential, such as Ebola. The company was founded in 2003 and is headquartered in Geneva, Switzerland. | - |
David L. Heymann | M | - |
Foundation for Innovative New Diagnostics
Foundation for Innovative New Diagnostics Medical/Nursing ServicesHealth Services Foundation for Innovative New Diagnostics provides healthcare services. It enables the development and delivery of much-needed diagnostic tests for poverty-related diseases, including tuberculosis, malaria, HIV/AIDS, sleeping sickness, hepatitis C, leishmaniasis, Chagas disease, Buruli ulcer, febrile illnesses and infectious diseases with outbreak potential, such as Ebola. The company was founded in 2003 and is headquartered in Geneva, Switzerland. | - |
Mark Clark | M | - |
Malaria Consortium
Malaria Consortium Medical/Nursing ServicesHealth Services Malaria Consortium is a non-profit organization that specializes in preventing, controlling, and treating malaria and other communicable diseases among vulnerable populations. The non-profit company is based in London, UK. Malaria Consortium's evidence-based programs combat targeted diseases and promote universal health coverage in Africa and Asia. The British company was founded in 2003 by Sylvia Meek, and the CEO is Charles Nelson. | - |
H. C Ursula Keller | M | 65 |
Swiss Federal Institute of Technology
| 31 years |
Christian Frutiger | M | - |
Foundation for Innovative New Diagnostics
Foundation for Innovative New Diagnostics Medical/Nursing ServicesHealth Services Foundation for Innovative New Diagnostics provides healthcare services. It enables the development and delivery of much-needed diagnostic tests for poverty-related diseases, including tuberculosis, malaria, HIV/AIDS, sleeping sickness, hepatitis C, leishmaniasis, Chagas disease, Buruli ulcer, febrile illnesses and infectious diseases with outbreak potential, such as Ebola. The company was founded in 2003 and is headquartered in Geneva, Switzerland. | - |
Sabrina Contratto | F | 51 |
Swiss Federal Institute of Technology
| - |
Philippe Block | M | 44 |
Swiss Federal Institute of Technology
| 15 years |
David Leppert | M | 66 |
University of Basel
| - |
Jean-François Ricci | M | - |
Swiss Federal Institute of Technology
| - |
Julia Dannath-Schuh | M | 47 |
Swiss Federal Institute of Technology
| 4 years |
Fredrik Hacklin | M | 46 |
Swiss Federal Institute of Technology
| - |
Anthony Davy | M | - |
Malaria Consortium
Malaria Consortium Medical/Nursing ServicesHealth Services Malaria Consortium is a non-profit organization that specializes in preventing, controlling, and treating malaria and other communicable diseases among vulnerable populations. The non-profit company is based in London, UK. Malaria Consortium's evidence-based programs combat targeted diseases and promote universal health coverage in Africa and Asia. The British company was founded in 2003 by Sylvia Meek, and the CEO is Charles Nelson. | - |
Allan Schapira | M | - |
Malaria Consortium
Malaria Consortium Medical/Nursing ServicesHealth Services Malaria Consortium is a non-profit organization that specializes in preventing, controlling, and treating malaria and other communicable diseases among vulnerable populations. The non-profit company is based in London, UK. Malaria Consortium's evidence-based programs combat targeted diseases and promote universal health coverage in Africa and Asia. The British company was founded in 2003 by Sylvia Meek, and the CEO is Charles Nelson. | - |
Roland Weiger | M | 63 |
University of Basel
| 22 years |
Neil Squires | M | - |
Malaria Consortium
Malaria Consortium Medical/Nursing ServicesHealth Services Malaria Consortium is a non-profit organization that specializes in preventing, controlling, and treating malaria and other communicable diseases among vulnerable populations. The non-profit company is based in London, UK. Malaria Consortium's evidence-based programs combat targeted diseases and promote universal health coverage in Africa and Asia. The British company was founded in 2003 by Sylvia Meek, and the CEO is Charles Nelson. | - |
Simon Kay | M | - |
Malaria Consortium
Malaria Consortium Medical/Nursing ServicesHealth Services Malaria Consortium is a non-profit organization that specializes in preventing, controlling, and treating malaria and other communicable diseases among vulnerable populations. The non-profit company is based in London, UK. Malaria Consortium's evidence-based programs combat targeted diseases and promote universal health coverage in Africa and Asia. The British company was founded in 2003 by Sylvia Meek, and the CEO is Charles Nelson. | - |
Precious Lunga | M | - |
Malaria Consortium
Malaria Consortium Medical/Nursing ServicesHealth Services Malaria Consortium is a non-profit organization that specializes in preventing, controlling, and treating malaria and other communicable diseases among vulnerable populations. The non-profit company is based in London, UK. Malaria Consortium's evidence-based programs combat targeted diseases and promote universal health coverage in Africa and Asia. The British company was founded in 2003 by Sylvia Meek, and the CEO is Charles Nelson. | - |
Peter Potter-Lesage | M | - |
Malaria Consortium
Malaria Consortium Medical/Nursing ServicesHealth Services Malaria Consortium is a non-profit organization that specializes in preventing, controlling, and treating malaria and other communicable diseases among vulnerable populations. The non-profit company is based in London, UK. Malaria Consortium's evidence-based programs combat targeted diseases and promote universal health coverage in Africa and Asia. The British company was founded in 2003 by Sylvia Meek, and the CEO is Charles Nelson. | - |
Brian Greenwood | M | - |
Malaria Consortium
Malaria Consortium Medical/Nursing ServicesHealth Services Malaria Consortium is a non-profit organization that specializes in preventing, controlling, and treating malaria and other communicable diseases among vulnerable populations. The non-profit company is based in London, UK. Malaria Consortium's evidence-based programs combat targeted diseases and promote universal health coverage in Africa and Asia. The British company was founded in 2003 by Sylvia Meek, and the CEO is Charles Nelson. | - |
Charles Nelson | M | - |
Malaria Consortium
Malaria Consortium Medical/Nursing ServicesHealth Services Malaria Consortium is a non-profit organization that specializes in preventing, controlling, and treating malaria and other communicable diseases among vulnerable populations. The non-profit company is based in London, UK. Malaria Consortium's evidence-based programs combat targeted diseases and promote universal health coverage in Africa and Asia. The British company was founded in 2003 by Sylvia Meek, and the CEO is Charles Nelson. | - |
Stewart Cole | M | - |
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative BiotechnologyHealth Technology Drugs for Neglected Diseases initiative provides drug research and development services. It specializes in analyzing the causes of and in developing medicine and treatments for neglected diseases. It specializes in the study of neglected tropical diseases, such as sleeping sickness (Human African Trypanosomiasis), Leishmaniasis, Chagas, malaria, pediatric HIV, and filarial diseases. It develops a research and development portfolio that includes projects from discovery through to post-registration phases. Its focus areas encompass regional disease-specific platform development, technology transfer, and public responsibility and awareness advocacies. The organization was founded in July 2003 and is headquartered in Geneva, Switzerland. | - |
Alwyn Mwinga | M | - |
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative BiotechnologyHealth Technology Drugs for Neglected Diseases initiative provides drug research and development services. It specializes in analyzing the causes of and in developing medicine and treatments for neglected diseases. It specializes in the study of neglected tropical diseases, such as sleeping sickness (Human African Trypanosomiasis), Leishmaniasis, Chagas, malaria, pediatric HIV, and filarial diseases. It develops a research and development portfolio that includes projects from discovery through to post-registration phases. Its focus areas encompass regional disease-specific platform development, technology transfer, and public responsibility and awareness advocacies. The organization was founded in July 2003 and is headquartered in Geneva, Switzerland. | - |
Michael Watson | M | - |
Foundation for Innovative New Diagnostics
Foundation for Innovative New Diagnostics Medical/Nursing ServicesHealth Services Foundation for Innovative New Diagnostics provides healthcare services. It enables the development and delivery of much-needed diagnostic tests for poverty-related diseases, including tuberculosis, malaria, HIV/AIDS, sleeping sickness, hepatitis C, leishmaniasis, Chagas disease, Buruli ulcer, febrile illnesses and infectious diseases with outbreak potential, such as Ebola. The company was founded in 2003 and is headquartered in Geneva, Switzerland. | - |
Roland Yves Siegwart | M | 65 |
Swiss Federal Institute of Technology
| 18 years |
Katarzyna Maria Jackowska | F | - |
Swiss Federal Institute of Technology
| 17 years |
Sarah Springman | M | 68 |
Swiss Federal Institute of Technology
| - |
Reto Francioni | M | 68 |
University of Basel
| 18 years |
Konrad Wegener | M | 66 |
Swiss Federal Institute of Technology
| 21 years |
Philipp J. Schönbucher | M | 55 |
Swiss Federal Institute of Technology
| - |
Johann Gottfried Hengartner | M | 80 |
Swiss Federal Institute of Technology
| - |
Peter Ryser | M | 72 |
Swiss Federal Institute of Technology
| 26 years |
Beth Krasna | F | 71 |
Swiss Federal Institute of Technology
| - |
Martin Gertsch | M | 59 |
University of Basel
| - |
Paul Embrechts | M | 71 |
Swiss Federal Institute of Technology
| 35 years |
George Candea | M | - |
Swiss Federal Institute of Technology
| - |
Gerhard Tröster | M | 70 |
Swiss Federal Institute of Technology
| 31 years |
Jutta Monika Heim | M | 73 |
University of Basel
| - |
Friedrich Fahrni | M | 82 |
Swiss Federal Institute of Technology
| 24 years |
Hedvig Kristina Andersén | F | 66 |
Swiss Federal Institute of Technology
| - |
Jasmin Staiblin | F | 54 |
Swiss Federal Institute of Technology
| - |
Fritz Melchers | M | - |
University of Basel
| - |
Barbara Anna Heller | F | 56 |
University of Basel
| 18 years |
Gottlieb A. Keller | M | 70 |
University of Basel
| - |
Thomas D. Szucs | M | 64 |
University of Basel
| - |
Shobana Kamineni | F | 63 |
Foundation for Innovative New Diagnostics
Foundation for Innovative New Diagnostics Medical/Nursing ServicesHealth Services Foundation for Innovative New Diagnostics provides healthcare services. It enables the development and delivery of much-needed diagnostic tests for poverty-related diseases, including tuberculosis, malaria, HIV/AIDS, sleeping sickness, hepatitis C, leishmaniasis, Chagas disease, Buruli ulcer, febrile illnesses and infectious diseases with outbreak potential, such as Ebola. The company was founded in 2003 and is headquartered in Geneva, Switzerland. | - |
Pius Baschera | M | 73 |
Swiss Federal Institute of Technology
| - |
Daniel Camus | M | 70 |
Foundation for Innovative New Diagnostics
Foundation for Innovative New Diagnostics Medical/Nursing ServicesHealth Services Foundation for Innovative New Diagnostics provides healthcare services. It enables the development and delivery of much-needed diagnostic tests for poverty-related diseases, including tuberculosis, malaria, HIV/AIDS, sleeping sickness, hepatitis C, leishmaniasis, Chagas disease, Buruli ulcer, febrile illnesses and infectious diseases with outbreak potential, such as Ebola. The company was founded in 2003 and is headquartered in Geneva, Switzerland. | - |
Ari Helenius | M | - |
Swiss Federal Institute of Technology
| 27 years |
Peter Schildknecht | M | 62 |
Swiss Federal Institute of Technology
| - |
Verena A. Briner | M | 72 |
University of Basel
| - |
Rudolf Marty | M | 75 |
Swiss Federal Institute of Technology
| - |
Mark Kessel | M | 82 |
Foundation for Innovative New Diagnostics
Foundation for Innovative New Diagnostics Medical/Nursing ServicesHealth Services Foundation for Innovative New Diagnostics provides healthcare services. It enables the development and delivery of much-needed diagnostic tests for poverty-related diseases, including tuberculosis, malaria, HIV/AIDS, sleeping sickness, hepatitis C, leishmaniasis, Chagas disease, Buruli ulcer, febrile illnesses and infectious diseases with outbreak potential, such as Ebola. The company was founded in 2003 and is headquartered in Geneva, Switzerland. | - |
Bradley J. Nelson | M | - |
Swiss Federal Institute of Technology
| 22 years |
Fritz Zurbrügg | M | 64 |
Swiss Federal Institute of Technology
| - |
Damir Filipovic | M | 54 |
Swiss Federal Institute of Technology
| - |
Elgar Fleisch | M | 56 |
Swiss Federal Institute of Technology
| - |
Lothar Thiele | M | - |
Swiss Federal Institute of Technology
| 30 years |
Peter Meier-Abt | M | - |
University of Basel
| - |
Hansje Güntherodt | M | - |
University of Basel
| - |
Peter J. Uggowitzer | M | 73 |
Swiss Federal Institute of Technology
| 43 years |
Luis Enrique Pizarro Maqueda | M | - |
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative BiotechnologyHealth Technology Drugs for Neglected Diseases initiative provides drug research and development services. It specializes in analyzing the causes of and in developing medicine and treatments for neglected diseases. It specializes in the study of neglected tropical diseases, such as sleeping sickness (Human African Trypanosomiasis), Leishmaniasis, Chagas, malaria, pediatric HIV, and filarial diseases. It develops a research and development portfolio that includes projects from discovery through to post-registration phases. Its focus areas encompass regional disease-specific platform development, technology transfer, and public responsibility and awareness advocacies. The organization was founded in July 2003 and is headquartered in Geneva, Switzerland. | 2 years |
Andrea Thaddaus Vasella | M | 81 |
Swiss Federal Institute of Technology
| 31 years |
Reza Abhari | M | 62 |
Swiss Federal Institute of Technology
| - |
Peter Chen | M | 64 |
Swiss Federal Institute of Technology
| 30 years |
John Martin Manser | M | 77 |
University of Basel
| - |
Henner Schierenbeck | M | 78 |
University of Basel
| 34 years |
Tuomas Waltimo | M | 53 |
University of Basel
| - |
Hanns Mohler | M | - |
Swiss Federal Institute of Technology
| - |
Eduard Rikli | M | 73 |
Swiss Federal Institute of Technology
| - |
François Diederich | M | 72 |
Swiss Federal Institute of Technology
| 32 years |
Ralph Müller | M | - |
Swiss Federal Institute of Technology
| - |
Soumya Swaminathan | M | - |
Foundation for Innovative New Diagnostics
Foundation for Innovative New Diagnostics Medical/Nursing ServicesHealth Services Foundation for Innovative New Diagnostics provides healthcare services. It enables the development and delivery of much-needed diagnostic tests for poverty-related diseases, including tuberculosis, malaria, HIV/AIDS, sleeping sickness, hepatitis C, leishmaniasis, Chagas disease, Buruli ulcer, febrile illnesses and infectious diseases with outbreak potential, such as Ebola. The company was founded in 2003 and is headquartered in Geneva, Switzerland. | 1 years |
Connections Chart
Multi-company connection
Statistics
Country | Connections | % of total |
---|---|---|
Germany | 47 | 47.00% |
Switzerland | 44 | 44.00% |
United Kingdom | 10 | 10.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Marcel Tanner
- Personal Network